| Product Name | : | Tofacinix |
| Generic Name | : | Tofacitinib |
| Formulation | : | Tablet |
| Available Pack Size | : | 3x10's Alu-Alu |
| Available Strength | : | 11 mg |
| Registrations | : | Export Only |
| Website | : | Tofacinix.com |
-
Product Description: Tofacitinib is indicated for the treatment of adult patients withmoderately to severely active rheumatoid arthritis who have hadan inadequate response or intolerance to methotrexate. It may beused as monotherapy or in combination with methotrexate orother nonbiologic disease-modifying antirheumatic drugs(DMARDs). Product Features: -
Product Description: Axinix (Axitinib) is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy. Product Features:Product Name : Axinix Generic Name : Axitinib Formulation : Tablet Available Pack Size : 180's Pot & 60's Po Available Strength : 1 mg & 5 mg Registrations : Export Only Website : Axinix.com -
Product Description: Lapatinib, a 4-anilinoquinazoline, is an inhibitor of the intracellular tyrosine kinase domains of both EGFR (ErbB1) and of HER2 (ErbB2) receptors. Lapatinib retained significant activity against HER2-amplified breast cancer cell lines selected for long-term growth in trastuzumab-containing medium in vitro and was synergistic in combination with trastuzumab in these cell lines. Product Features:Product Name : Lapanix Generic Name : Lapatinib Formulation : Tablet Available Pack Size : 150's Pot Available Strength : 250 mg Registrations : Export Only Website : Lapanix.com -
Product Description: Baricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs. Baricitinib may be used as monotherapy or in combination with Methotrexate. Product Features:Product Name : Baricinix Generic Name : Baricitinib Formulation : Tablet Available Pack Size : 30's Pot Available Strength : 2mg & 4mg Registrations : Export Only Website : Baricinix.com -
Product Description: Palbociclib is indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with:- an aromatase inhibitor as initial endocrine based therapy in postmenopausal women.
- fulvestrant in women with disease progression following endocrine therapy.
Product Name : Palbonix Generic Name : Palbociclib Formulation : Capsule Available Pack Size : 21's Pot Available Strength : 125mg Registrations : Export Only Website : Palbonix.com -
Product Description: Cabozanix is a multiple Tyrosine Kinase inhibitor that is indicated for the treatment of Renal Cell Carcinoma and Metastatic Thyroid Cancer. Product Features:Product Name : Cabozanix Generic Name : Cabozanitib Formulation : Tablet Available Pack Size : 90's Pot & 30's Pot Available Strength : 20mg & 60mg Registrations : Export Only Website : Cabozanix.com -
Product Description: Obetix is the only choice for Primary Biliary Cirrhosis (PBC) with the combination of UDCA (Ursodeoxycholic Acid) Product Features:Product Name : Obetix 5 Generic Name : Obeticholic Acid Formulation : Tablet Available Pack Size : 30's Pot Available Strength : 5 mg Registrations : Export Only Website : Obetix.com -
Product Description:
Tafecta is the 1st global generic of Tenofovir Alafenamide. Tenofovir Alafenamide is an oral nucleoside reverse transcriptase inhibitor (NRTIs).Itis indicated for the treatment of chronic hepatitis b virus (HBV) infection in adults with compensated liver disease. Indication and Usage: Tafecta is a hepatitis B virus (HBV) nucleoside analog reverse transcriptase inhibitor and is indicated for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease. Product Features:
Categories: Anti-Viral, Biotech Product, Drugs to Treat HepatitisProduct Name : Tafecta Generic Name :Tenofovir Alafenamide Formulation :Solid dosage form(Tablet) Available size : 3×10’s Strengths : 25mg Registrations : Bangladesh Website : www.tafecta.com -
Sofosvel is the global first generic oral tablet for pan-genotypic Chronic Hepatitis C treatment. This combination (Sofosbuvir 400 mg + Valpatasvir 100 mg) drug has been approved by US FDA & European Commission for treatment of patients with all genotypic Chronic Hepatitis C virus infection. Sofosvel is used without cirrhosis or with compensated cirrhosis, and patients with advanced cirrhosis (Decompensated).
Therapeutic indications:
Sofosvel is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infections
- With or without cirrhosis or with compensated cirrhosis
- With decompensated cirrhosis for use in combination with Ribavirin
Product Name : Sofosvel
Generic Name : Sofosbuvir 400mg + Velpatasvir 100 mg
Formulation : Solid dosage form(Tablet)
Available pack size : 1×6’s
Strengths : 400mg+ 100mg
-
Product Description: Entecavir is a guanosine analogue with marked activity against HBV DNA polymerase. It is licensed for the treatment of chronic Hepatitis B virus infection in patients with compensated liver disease and evidence of acute viral replication, persistently elevated serum alanine aminotransferase levels and histological evidence of active inflammation and/or fibrosis.
Product Features:Product Name : Caviral Generic Name : Entecavir Formulation : Tablet Available Pack Size : 1x10’s Available Strength : 0.5 mg Registrations : Bangladesh -
Product Description: TENOFOVIR is an antiretroviral agent, which belongs to a class of drugs called “nucleotide reverse transcriptase inhibitor” or “NtRTI.” TENOFOVIR mimics a nucleoside base, which blocks further construction of the virus. When combined with other antiretroviral agents, TENOFOVIR can achieve a significant decrease in viral multiplication.
Product Features:Product Name : Becovir Generic Name : Tenofovir Disoproxil Fumarate Formulation : Tablet Available Pack Size : 1x8’s Available Strength : 300 mg Registrations : Bangladesh -
Product Description: Daclavir (Daclatasvir) is one of the new direct-acting antiviral drugs that target different steps of the hepatitis C virus (HCV) lifecycle. It is the first-ever approved HCV NS5A replication complex inhibitor, meaning it interferes with a protein the virus uses to reproduce.
Product Features:Product Name : Daclavir Generic Name : Daclatasvir Formulation : Tablet Available Pack Size : 1x10’s Available Strength : 60 mg Registrations : Bangladesh